OncoVet: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OncoVet
Largest movements
- Receivables within one year +€15,475
up €15,475 (+339.8%), from €4,554 to €20,029
of which Trade receivables: +€11,206
- Cash +€7,103
up €7,103 (+29.4%), from €24,127 to €31,230
mainly Net result for the year (+€16,565) and Other debts (+€8,168)
- Reserves +€16,565
up €16,565 (+97.8%), from €16,934 to €33,499
- Other debts +€8,168
up €8,168 (+200.8%), from €4,067 to €12,235
- Trade debts -€3,223
down €3,223 (-74.5%), from €4,324 to €1,101
- Tax, wage and social debts +€1,140
up €1,140 (+24.3%), from €4,700 to €5,841
- Gross operating margin +€2,278
up €2,278 (+10.0%), from €22,701 to €24,978
- Depreciation +€1,222
up €1,222 (+1293.0%), from €95 to €1,317
- Other operating charges +€999
up €999 (+84.1%), from €1,188 to €2,186
- Taxes +€285
up €285 (+6.4%), from €4,446 to €4,731
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €32,026 | €54,675 | +€22,650 | +70.7% |
| Fixed assets | 21/28 | €3,344 | €3,246 | -€98 | -2.9% |
| Tangible fixed assets | 22/27 | €3,344 | €3,246 | -€98 | -2.9% |
| Plant, machinery and equipment | 23 | €1,702 | €1,933 | +€230 | +13.5% |
| Furniture and vehicles | 24 | €1,642 | €1,314 | -€328 | -20.0% |
| Current assets | 29/58 | €28,682 | €51,429 | +€22,748 | +79.3% |
| Amounts receivable within one year | 40/41 | €4,554 | €20,029 | +€15,475 | +339.8% |
| Trade receivables | 40 | - | €11,206 | +€11,206 | |
| Other amounts receivable | 41 | €4,554 | €8,823 | +€4,269 | +93.7% |
| Cash at bank and in hand | 54/58 | €24,127 | €31,230 | +€7,103 | +29.4% |
| Deferred charges and accrued income | 490/1 | - | €170 | +€170 | |
| Total equity and liabilities | 10/49 | €32,026 | €54,675 | +€22,650 | +70.7% |
| Equity | 10/15 | €18,934 | €35,499 | +€16,565 | +87.5% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €16,934 | €33,499 | +€16,565 | +97.8% |
| Distributable reserves | 133 | €16,934 | €33,499 | +€16,565 | +97.8% |
| Amounts payable | 17/49 | €13,092 | €19,177 | +€6,085 | +46.5% |
| Amounts payable within one year | 42/48 | €13,092 | €19,177 | +€6,085 | +46.5% |
| Trade debts | 44 | €4,324 | €1,101 | -€3,223 | -74.5% |
| Suppliers | 440/4 | €4,324 | €1,101 | -€3,223 | -74.5% |
| Taxes, remuneration and social security | 45 | €4,700 | €5,841 | +€1,140 | +24.3% |
| Taxes | 450/3 | €4,700 | €5,841 | +€1,140 | +24.3% |
| Other amounts payable | 47/48 | €4,067 | €12,235 | +€8,168 | +200.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €95 | €1,317 | +€1,222 | +1293.0% |
| Other operating charges | 640/8 | €1,188 | €2,186 | +€999 | +84.1% |
| Gross operating margin | 9900 | €22,701 | €24,978 | +€2,278 | +10.0% |
| Operating profit (loss) | 9901 | €21,418 | €21,475 | +€57 | +0.3% |
| Financial charges | 65/66B | €39 | €179 | +€140 | +362.0% |
| Recurring financial charges | 65 | €39 | €179 | +€140 | +362.0% |
| Profit (loss) for the period before taxes | 9903 | €21,380 | €21,296 | -€84 | -0.4% |
| Income taxes | 67/77 | €4,446 | €4,731 | +€285 | +6.4% |
| Profit (loss) for the period | 9904 | €16,934 | €16,565 | -€369 | -2.2% |
| Profit (loss) for the period to be appropriated | 9905 | €16,934 | €16,565 | -€369 | -2.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.